Manufacturer record
Laborate Pharmaceuticals India Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
26 batches manufactured by Laborate Pharmaceuticals India Ltd (Himachal Pradesh) were declared Not of Standard Quality between April 2020 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: PAMLA002, Paracetamol Paediatric Oral Suspension IP (exp Jul 2027). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to IP in respect of content of Paracetamol. Listed in the September 2026 alert.
Records by type
26 records linked to Laborate Pharmaceuticals India Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Paediatric Oral Suspension IP | Batch PAMLA002Mfg Aug 2025 · Exp Jul 2027 | The sample does not conform to IP in respect of content of Paracetamol.Other | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Cefixime Dispersible Tablets I.P. | Batch PYITL003Mfg May 2025 · Exp Apr 2027 | DESCRIPTION ? TABLETS HAVING BROWN COLOR SPOTS ON SURFACE.Description | SDTL, UttarakhandState lab | Sep 2026 |
| Paracetamol Tablets IP | Batch PPETL009Mfg Oct 2025 · Exp Sep 2028 | The sample does not conform to standard quality in respect of the test for Dissolution performed.Dissolution | SDTL, Agartala, Govt. of TripuraState lab | Aug 2026 |
| Dexamethasone Injection IP-2ml | Batch TDDUI-005Mfg Oct 2025 · Exp Sep 2027 | AssayAssay | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab | Aug 2026 |
| Dexamethasone Injection I.P -2ml | Batch CDDUI-008Mfg Dec 2025 · Exp Nov 2027 | AssayAssay | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab | Aug 2026 |
| Calcium and Vitamin D3 Tablets IP 500mg/250 IU | Batch PJCT-021Mfg Feb 2025 · Exp Jan 2027 | Identification of Vitamin D3 - Doesn't conforms to I.P.Identification | Lucknow LabState lab | Jul 2026 |
| Ampicillin & Cloxacillin Capsules, Mediclox- Plus (as per Front Side of The sample strips), Betamox Plus (as per back side of The sample strips) and Amoxycillin, Cloxacillin & Lactic Acid Bacillus Capsules (As per Form 18) | Batch PBEAL001Mfg Feb 2025 · Exp Jan 2027 | The sample does not conform to claim with respect to Identification and Assay of Ampicillin. The sample is found to contain 246.8 mg Amoxycillin per capsule however, there is no label claim for Amoxycillin in The sample. The sample is deemed to be misbranded drug vide Section 17 of Drugs and Cosmetics Act 1940 and Rule thereunder.Assay | CDL, KolkataCDSCO lab | May 2026 |
| Aceclofenac, Paracetamol Tablets | Batch ACPUT-004Mfg Jul 2025 · Exp Jun 2028 | MisbrandadMisbranded | SDTL, ChhattisgarhState lab | May 2026 |
| Rabeprazole & Domperidone Capsules | Batch ORECA-007Mfg Oct 2024 · Exp Sep 2026 | The sample does not conform to Manufacturer's Specification with respect to the Test of Dissolution of Rabeprazole Sodium in acid and buffer stage.Dissolution | CDL, KolkataCDSCO lab | Feb 2026 |
| Paracetamol I.P 500 mg (PARA 500) | Batch NBRT-018Mfg May 2023 · Exp Apr 2026 | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab | Oct 2025 |
| Paracetamol I.P 500 mg (PARA 500) | Batch NBRT-018Mfg May 2023 · Exp Apr 2026 | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab | Oct 2025 |
| Calcium and Vitamin D3 Tablets I.P. 500mg/250 I.U | Batch OJCT-009Mfg Dec 2024 · Exp Nov 2026 | Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Deco (Chloramphenicol & Betamethasone Sodium Sodium Phosphate eye/ear Drops) | Batch NDCO-019Mfg Oct 2023 · Exp Sep 2025 | The Sample dose not conforms to claim as per Patent & Proprietary in respect to assay of Chloramphenicol.Assay | Drug Testing Laboratory Baddi, Himanchal PradeshState lab | Jul 2025 |
| Amoxycillin Trihydrate Capsules I.P. (Zymox-500 (Yellow)) | Batch ZYMC-2407Mfg Apr 2024 · Exp Apr 2026 | Assay/ content of AmoxycillinAssay | CDTL-MumbaiCDSCO lab | May 2025 |
| Paracetamol, Phenylephrine HCL & Cetrizine HCL Suspension | Batch OKOL-009Mfg Jul 2024 · Exp Jun 2026 | The sample does not conform to claim as per Patent and Proprietary in respect of the assay of Phenylephrine Hydrochloride.Assay | DTL BaddiState lab | Apr 2025 |
| Gentamicin Sulphate Injection I.P. 30 ml (Gentalab) | Batch OGNI-037Mfg Jul 2024 · Exp Jun 2026 | Particulate matter and DescriptionDescription | CDL, KolkataCDSCO lab | Mar 2025 |
| Dexamethasone Injection IP-2ml | Batch FDDTI-004Mfg Feb 2024 · Exp Jan 2026 | Sample does not conform to requirement for Assay.Assay | King Institute ChennaiState lab | Dec 2024 |
| Amoxycillin Oral Suspension I.P. (Medmoxil 125) | Batch XMSD-001Mfg Mar 2023 · Exp Aug 2024 | StabilityOther | CDL KolkataCDSCO lab | Feb 2024 |
| MAFNAC-SPAS (MEFENAMIC ACID & PARACETAMOL TABLETS) | Batch MFNT-001Mfg Mar 2022 · Exp Feb 2025 | Disintegration and DescriptionDescription | CDL KolkataCDSCO lab | Dec 2023 |
| DSP (Diclofenac Potassium Serratiopeptidase & Paracetamol Tablets) | Batch LSAT-016Mfg Jun 2021 · Exp May 2023 | DescriptionDescription | RDTL GuwahatiState lab | Dec 2022 |
| OMECAP (Omeprazole Capsules IP 20 mg) | Batch LPOC-035Mfg Jul 2021 · Exp Jun 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
| Ciprofloxacin Tablets I.P. | Batch LCCT-001Mfg May 2021 · Exp Apr 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2022 |
| Paracetamol Tablets IP | Batch LPST-004Mfg May 2021 · Exp Apr 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Mar 2022 |
| Doxycycline and Ambroxol Capsules (DOXYLAB CAPSULES) | Batch DBQC-004Mfg Oct 2021 · Exp Sep 2023 | Assay of DoxycyclineAssay | RDTL ChandigarhState lab | Feb 2022 |
| Diazepam Injection I.P. (Diazelab) | Batch KDZI-001Mfg Feb 2020 · Exp Jan 2022 | MisbrandedMisbranded | RDTL GuwahatiState lab | Dec 2021 |
| Chloramphenicol Capsules I.P. (LABCHLOR 500) | Batch JLGC-003Mfg May 2019 · Exp Apr 2021 | DissolutionDissolution | RDTL GuwahatiState lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.